Author/Creator: Ellis, Lorie A. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Ellis, Lorie A.

1. A real-world, multi-site, observational study of infusion time and treatment satisfaction with rheumatoid arthritis patients treated with intravenous golimumab or infliximab. (3rd July 2018)

Authors:: Daniel, Shoshana R.; McDermott, John D.; Le, Cathy; Pierce, Christine A.; Ziskind, Michael A.; Ellis, Lorie A.
Journal:: Journal of medical economics
Issue:: Volume 21:Number 7(2018)
Page Start:: 724
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Assessment of Evidence‐Based Standards in the Treatment of Advanced Prostate Cancer in a Community Practice. Issue 3 (May 2017)

Authors:: Pilon, Dominic; Ellis, Lorie A.; Behl, Ajay S.; Gozalo, Laurence; Emond, Bruno; Lefebvre, Patrick; Calabrese, Renee; Prime, Hilary; Gaylis, Franklin
Journal:: Urology practice
Issue:: Volume 4:Issue 3(2017)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Consideration of Potential Drug–Drug Interactions in Selection of FDA-Approved Drugs Indicated for Prostate Cancer. (May 2019)

Authors:: Pilon, Dominic; Ellis, Lorie A.; Xiao, Yongling; Behl, Ajay S.; Lefebvre, Patrick
Journal:: American journal of therapeutics
Issue:: Volume 26:Number 3(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Cost per median overall survival month associated with abiraterone acetate and enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer. (2nd August 2016)

Authors:: Pilon, Dominic; Queener, Marykay; Lefebvre, Patrick; Ellis, Lorie A.
Journal:: Journal of medical economics
Issue:: Volume 19:Number 8(2016)
Page Start:: 777
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors. (3rd October 2019)

Authors:: Emond, Bruno; Ellis, Lorie A.; Chakravarty, Soumya D.; Ladouceur, Martin; Lefebvre, Patrick
Journal:: Current medical research and opinion
Issue:: Volume 35:Number 10(2019)
Page Start:: 1751
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗